{"classification":[{"coding":[{"code":"protein","display":"Protein","system":"http://example.europa.eu/fhir/SubstanceType"}]}],"code":[{"code":{"coding":[{"code":"TRAS9123H","system":"http://example.europa.eu/fhir/Substance"}]}}],"description":"Trastuzumab — humanised IgG1 monoclonal antibody targeting the human epidermal growth factor receptor 2 (HER2/ErbB2). Variable regions derived from murine antibody 4D5, grafted onto human IgG1 framework. Produced in Chinese hamster ovary (CHO) cells.","domain":{"coding":[{"code":"human","display":"Human use","system":"http://example.europa.eu/fhir/Domain"}]},"id":"trastuzumab","identifier":[{"system":"http://example.europa.eu/fhir/SMSId","value":"TRAS9123H"}],"name":[{"language":[{"coding":[{"code":"en","display":"English","system":"urn:ietf:bcp:47"}]}],"name":"Trastuzumab","official":[{"authority":{"coding":[{"code":"INN","display":"INN","system":"http://hl7.org/fhir/substance-name-authority"}]},"status":{"coding":[{"code":"active","display":"Active","system":"http://hl7.org/fhir/publication-status"}]}}],"preferred":true},{"name":"Herceptin","preferred":false}],"protein":{"disulfideLinkage":["HC22-HC96; HC144-HC200; HC222-LC214; HC228-HC228'; HC231-HC231'; HC265-HC325; HC371-HC429"],"gene":[{"gene":{"concept":{"coding":[{"code":"IGHG1","display":"Immunoglobulin heavy constant gamma 1","system":"http://www.genenames.org"}]}},"sequenceOrigin":{"coding":[{"code":"humanised-mouse","display":"Humanised mouse","system":"http://hl7.org/fhir/gene-sequence-origin"}]}}],"numberOfSubunits":2,"sequenceType":{"coding":[{"code":"complete","display":"Complete","system":"http://hl7.org/fhir/substance-sequence-type"}]},"subunit":[{"cTerminalModification":{"concept":{"coding":[{"code":"lysine-clipped","display":"C-terminal lysine clipping","system":"http://example.europa.eu/fhir/Modification"}]}},"length":450,"nTerminalModification":{"concept":{"coding":[{"code":"pyroglutamate","display":"Pyroglutamic acid (pE)","system":"http://example.europa.eu/fhir/Modification"}]}},"sequence":"EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS...","subunit":1},{"length":214,"sequence":"DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK...","subunit":2}]},"relationship":[{"amountQuantity":{"code":"nmol/L","system":"http://unitsofmeasure.org","unit":"nM","value":0.1},"interaction":{"coding":[{"code":"binding","display":"Binding","system":"http://hl7.org/fhir/substance-interaction-type"}]},"measurementType":{"coding":[{"code":"kd","display":"Kd","system":"http://hl7.org/fhir/substance-measurement-type"}]},"substanceDefinitionReference":{"display":"Receptor tyrosine-protein kinase erbB-2 (HER2)","reference":"SubstanceDefinition/her2"},"type":{"coding":[{"code":"TherapeuticTarget","display":"Therapeutic target","system":"http://hl7.org/fhir/substance-relationship-type"}]}}],"resourceType":"SubstanceDefinition","status":{"coding":[{"code":"active","display":"Active","system":"http://hl7.org/fhir/publication-status"}]}}